Cargando…
Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is the sixth leading cause of cancer death in the US. The protein kinase D (PKD) family has emerged as a promising target for cancer therapy with PKD1 being most intensively studied; however, its role in HNSCC has not been investigated. METHO...
Autores principales: | Zhang, Liyong, Li, Zhihong, Liu, Yehai, Xu, Shuping, Tandon, Manuj, Appelboom, Brittany, LaValle, Courtney R., Chiosea, Simion I., Wang, Lin, Sen, Malabika, Lui, Vivian W. Y., Grandis, Jennifer R., Wang, Q. Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233608/ https://www.ncbi.nlm.nih.gov/pubmed/30419840 http://dx.doi.org/10.1186/s12885-018-4965-6 |
Ejemplares similares
-
Androgen suppresses protein kinase D1 expression through fibroblast growth factor receptor substrate 2 in prostate cancer cells
por: Zhang, Liyong, et al.
Publicado: (2017) -
JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth()()
por: Sen, Malabika, et al.
Publicado: (2015) -
Nucleic acid-based approaches to STAT inhibition
por: Sen, Malabika, et al.
Publicado: (2012) -
Design, Synthesis, and Biological Evaluation of PKD Inhibitors
por: George, Kara M., et al.
Publicado: (2011) -
New Pyrazolopyrimidine Inhibitors of Protein Kinase D as Potent Anticancer Agents for Prostate Cancer Cells
por: Tandon, Manuj, et al.
Publicado: (2013)